Remarkably, silencing of SRSF3 and HNRNPM, impacts on DHX9 expression as well as on Ewing sarcoma cell viability and proliferation, while it reduces survival of Ewing sarcoma cells to doxorubicin treatment. The gene discussed is SRSF3; the disease is Ewing sarcoma.